Goldman Sachs cuts Nanobiotix stake to 3.78%
Bitget2026/09/21 11:17- Goldman Sachs cut its stake in Nanobiotix below 5% on Aug. 24.
- Holding fell to 1,921,176 shares, equal to 3.78% of share capital, 3.52% of voting rights.
- Move followed an off-market sale of shares.
- Position includes 1,478,840 shares via 17 cash-settled swap contracts, exercisable through Aug. 20, 2036.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
InnovAge Prices Secondary Offering of 10 Million Shares
TUI managing body member Helmut Reiner Sebastian Ebel buys shares for EUR 32,650
Angi Names Michael Steib as CEO
JPMorgan: HBM specification downgrade does not change the tight supply, demand CAGR remains at 63% from 2026 to 2028
JPMorgan recently released an industry report on the HBM storage sector, addressing market concerns about the downgrade of HBM specifications and providing updates on industry supply and demand, downstream demand, technological iteration, manufacturer competition, and investment assessments.
Crypto prices
More
